Item Type | Name |
Academic Article
|
Comparison of incremental with multipoint MUNE methods in transgenic ALS mice.
|
Academic Article
|
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.
|
Academic Article
|
Variants in the ALS2 gene are not associated with sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.
|
Academic Article
|
RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells.
|
Academic Article
|
Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.
|
Academic Article
|
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
|
Academic Article
|
No association of DYNC1H1 with sporadic ALS in a case-control study of a northern European derived population: a tagging SNP approach.
|
Academic Article
|
Caspase-3 cleaves and inactivates the glutamate transporter EAAT2.
|
Academic Article
|
Case records of the Massachusetts General Hospital. Case 22-2006--a 77-year-old man with a rapidly progressive gait disorder.
|
Academic Article
|
Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis.
|
Academic Article
|
Two approaches to drug discovery in SOD1-mediated ALS.
|
Academic Article
|
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
|
Academic Article
|
Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality.
|
Academic Article
|
Birth order and the genetics of amyotrophic lateral sclerosis.
|
Academic Article
|
Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats.
|
Academic Article
|
Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS.
|
Academic Article
|
A common haplotype within the PON1 promoter region is associated with sporadic ALS.
|
Academic Article
|
Developmental biology. Neuron research leaps ahead.
|
Academic Article
|
Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.
|
Academic Article
|
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.
|
Academic Article
|
Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.
|
Academic Article
|
XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy.
|
Academic Article
|
A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q.
|
Academic Article
|
Medicine. A reinnervating microRNA.
|
Academic Article
|
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2.
|
Academic Article
|
Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions.
|
Academic Article
|
Paraoxonase gene mutations in amyotrophic lateral sclerosis.
|
Academic Article
|
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.
|
Academic Article
|
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.
|
Academic Article
|
Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G??A transgenic ALS mice.
|
Academic Article
|
A yeast model of FUS/TLS-dependent cytotoxicity.
|
Academic Article
|
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.
|
Academic Article
|
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.
|
Academic Article
|
Mutant dynactin in motor neuron disease.
|
Academic Article
|
Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
|
Academic Article
|
Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis.
|
Academic Article
|
An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis.
|
Academic Article
|
Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis.
|
Academic Article
|
Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation.
|
Academic Article
|
Amyotrophic lateral sclerosis--a new role for old drugs.
|
Academic Article
|
Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes.
|
Academic Article
|
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.
|
Academic Article
|
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis.
|
Academic Article
|
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.
|
Academic Article
|
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
DNA sequence analysis of the conserved region around the SOD1 gene locus in recessively inherited ALS.
|
Academic Article
|
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.
|
Academic Article
|
RNA metabolism and the pathogenesis of motor neuron diseases.
|
Academic Article
|
Vanadium, aluminum, magnesium and manganese are not elevated in hair samples in amyotrophic lateral sclerosis.
|
Academic Article
|
A large genome scan for rare CNVs in amyotrophic lateral sclerosis.
|
Academic Article
|
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
|
Academic Article
|
Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS.
|
Academic Article
|
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.
|
Academic Article
|
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
|
Concept
|
Motor Neuron Disease
|
Concept
|
Amyotrophic Lateral Sclerosis
|
Academic Article
|
Amyotrophic lateral sclerosis: Problems and prospects.
|
Academic Article
|
Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
|
Academic Article
|
ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
|
Academic Article
|
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
|
Academic Article
|
ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation.
|
Academic Article
|
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.
|
Academic Article
|
Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.
|
Academic Article
|
Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.
|
Academic Article
|
Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.
|
Academic Article
|
The distinct genetic pattern of ALS in Turkey and novel mutations.
|
Academic Article
|
Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients.
|
Academic Article
|
Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2.
|
Academic Article
|
Endogenous retroviruses in ALS: A reawakening?
|
Academic Article
|
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.
|
Academic Article
|
Amyotrophic Lateral Sclerosis: Review.
|
Academic Article
|
Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
|
Academic Article
|
Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
|
Academic Article
|
ALS-linked protein disulfide isomerase variants cause motor dysfunction.
|
Academic Article
|
Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
|
Academic Article
|
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
|
Academic Article
|
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
|
Academic Article
|
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.
|
Academic Article
|
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.
|
Academic Article
|
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
|
Academic Article
|
Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
|
Academic Article
|
Metabolomic analysis and signatures in motor neuron disease.
|
Academic Article
|
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.
|
Academic Article
|
Further analysis of KIFAP3 gene in ALS patients from Switzerland and Sweden.
|
Academic Article
|
Restrictive Lung Disease in the Cu/Zn Superoxide-Dismutase 1 G93A Amyotrophic Lateral Sclerosis Mouse Model.
|
Academic Article
|
Genetics of Amyotrophic Lateral Sclerosis.
|
Academic Article
|
Silencing strategies for therapy of SOD1-mediated ALS.
|
Academic Article
|
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.
|
Academic Article
|
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
|
Academic Article
|
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.
|
Academic Article
|
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
|
Academic Article
|
Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.
|
Academic Article
|
Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis.
|
Academic Article
|
Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
|
Academic Article
|
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis.
|
Academic Article
|
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function.
|
Academic Article
|
Finding a Treatment for ALS - Will Gene Editing Cut It?
|
Academic Article
|
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
|
Academic Article
|
Amyotrophic Lateral Sclerosis.
|
Academic Article
|
A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS.
|
Academic Article
|
Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis.
|
Academic Article
|
Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers.
|
Academic Article
|
NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
|
Academic Article
|
Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology.
|
Academic Article
|
Longitudinal biomarkers in amyotrophic lateral sclerosis.
|
Academic Article
|
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
|
Academic Article
|
Amyotrophic Lateral Sclerosis: Fuel for the Corticofugal Feud.
|
Academic Article
|
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models.
|
Academic Article
|
Single breath counting is an effective screening tool for forced vital capacity in ALS.
|
Academic Article
|
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
|
Academic Article
|
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.
|
Academic Article
|
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
|
Academic Article
|
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
|
Academic Article
|
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
|
Academic Article
|
Imaging Net Retrograde Axonal Transport In Vivo: A Physiological Biomarker.
|
Academic Article
|
Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons.
|
Academic Article
|
Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3'UTR protect against ALS.
|
Academic Article
|
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
|
Academic Article
|
CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.
|
Academic Article
|
Approaches to Gene Modulation Therapy for ALS.
|
Academic Article
|
Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons.
|
Academic Article
|
Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice.
|
Academic Article
|
Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo.
|
Academic Article
|
Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis.
|
Academic Article
|
Amyotrophic lateral sclerosis.
|
Academic Article
|
PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS.
|
Academic Article
|
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.
|
Academic Article
|
Corrigendum: XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy.
|
Academic Article
|
Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
|